Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-09
DOI
10.3389/fimmu.2019.00496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy?
- (2017) Jennifer P Morton et al. Immunotherapy
- Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma
- (2017) Ishan Roy et al. LABORATORY INVESTIGATION
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy
- (2017) Reza Nejati et al. PANCREAS
- Pancreatic stellate cell: Pandora's box for pancreatic disease biology
- (2017) Ratnakar R Bynigeri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
- (2016) Engin Gürlevik et al. GASTROENTEROLOGY
- Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
- (2016) Qingda Meng et al. JOURNAL OF IMMUNOTHERAPY
- CXCR2 signaling regulates KRAS(G12D)-induced autocrine growth of pancreatic cancer
- (2016) Abhilasha Purohit et al. Oncotarget
- Prognostic value of PDL1 expression in pancreatic cancer
- (2016) David J. Birnbaum et al. Oncotarget
- CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
- (2016) T. Chao et al. Cancer Immunology Research
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
- (2015) Cheng Sun et al. ACTA PHARMACOLOGICA SINICA
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Systemic Immune Activity Predicts Overall Survival in Treatment-Nai ve Patients with Metastatic Pancreatic Cancer
- (2015) M. R. Farren et al. CLINICAL CANCER RESEARCH
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Characterization of tumor infiltrating natural killer cell subset
- (2015) Inbar Levi et al. Oncotarget
- The role of hypoxia in pancreatic cancer: a potential therapeutic target?
- (2015) Mert Erkan et al. Expert Review of Gastroenterology & Hepatology
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- Is the Tumor Infiltrating Natural Killer Cell (NK-TILs) Count in Infiltrating Ductal Carcinoma of Breast Prognostically Significant?
- (2014) Ankita Singh Rathore et al. Asian Pacific Journal of Cancer Prevention
- Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
- (2014) Yun-Peng Peng et al. BMC CANCER
- CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets
- (2014) M. T. M. Vossen et al. JOURNAL OF IMMUNOLOGY
- Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
- (2014) Kendall C. Shibuya et al. PLoS One
- TGFβ signaling in pancreatic ductal adenocarcinoma
- (2014) Hui Zhang et al. TUMOR BIOLOGY
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy
- (2013) S. A. Lim et al. CANCER RESEARCH
- CXCR2: a target for pancreatic cancer treatment?
- (2013) Kathleen M Hertzer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
- (2013) Yun-Peng Peng et al. Journal of Translational Medicine
- Immune infiltrates as predictive markers of survival in pancreatic cancer patients
- (2013) Maria Pia Protti et al. Frontiers in Physiology
- An Exploratory Study of Inflammatory Cytokines as Prognostic Biomarkers in Patients With Ductal Pancreatic Adenocarcinoma
- (2012) Simona O. Dima et al. PANCREAS
- Desmoplasia in Pancreatic Cancer. Can We Fight It?
- (2012) E. E. Merika et al. Gastroenterology Research and Practice
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer
- (2011) J. Matsubara et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Identification and characterization of a tumor infiltrating CD56+/CD16− NK cell subset with specificity for pancreatic and prostate cancer cell lines
- (2010) Timothy L. Frankel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
- (2010) W. Peng et al. CLINICAL CANCER RESEARCH
- FK506 causes cellular and functional defects in human natural killer cells
- (2010) Tae-Jin Kim et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection
- (2008) Agnes Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now